Navigation Links
Missed opportunities: Most heart attack patients are not taking preventive medications
Date:11/15/2010

Despite a high frequency of cardiac risk factors, patients without known coronary artery disease (CAD) presenting with acute heart attacks, or ST-elevated myocardial infarction (STEMI), are rarely on primary prevention medications, according to study findings to be presented Nov. 15 at the 2010 annual American Heart Association (AHA) Scientific Sessions in Chicago.

The decreasing incidence of STEMI due to acute coronary thrombosis is at least partially related to increased use of primary and secondary prevention, in particular anti-platelet and lipid-lowering therapies, according to the study authors. Still, nearly 400,000 present annually with STEMI in the United States.

"We hypothesized that the use of evidence-based preventive therapy in patients presenting with STEMI would be sub-optimal," says study investigator Kevin J. Graham, MD, president of the Minneapolis Heart Institute at Abbott Northwestern Hospital in Minneapolis.

As part of the Minneapolis Heart Institute Level 1 MI program, which uses a standardized protocol for percutaneous coronary invention (PCI) in STEMI patients in 32 rural and community hospitals, preadmission medications in patients admitted with STEMI are recorded using each patient's electronic medical record.

The researchers assessed the percentage of patients treated with aspirin, statins, and ACE-inhibitors in patients with and without previously diagnosed CAD. From May 1, 2007 to March 1, 2010, they enrolled 1,174 patients with documented STEMI358 with known CAD and 816 without known CAD.

"For those patients with known CAD, 100 percent should be taking aspirin and 90 percent on a statin, but we found only 70 percent were taking aspirin and only 61 percent were taking a statin," explains Graham. "Equally disconcerting is the 815 patients without known coronary disease, half of whom had hypertension and slightly less than half had known hyperlipidemia, and only 22 percent were taking aspirin and 16 percent were taking a statin."

The study authors suggest that the potential reasons for this gap include absence of indications for primary prevention by current guidelines, no previous medical care, inadequate risk factor identification and modification or non-compliance. They add that the use of secondary prevention medication in patients with known CAD was "significantly lower than expected."

"Efforts aimed at detecting early cardiovascular disease and better compliance with appropriate preventive cardiovascular medications may, if successful, produce even further reductions in cardiovascular morbidity and mortality," the researchers conclude.

"Prevention works. These findings speak strongly to the benefits of initiating and maintaining appropriate medication regimens in at-risk patients to prevent vascular events," concludes Graham.


'/>"/>

Contact: Meghan Bethke
mbethke@mhif.org
612-863-5410
Minneapolis Heart Institute Foundation
Source:Eurekalert

Related medicine news :

1. Outcomes of patients dismissed from the hospital with non-cardiac chest pain
2. Many Kids With Hepatitis C Are Missed
3. 1 in 5 Parents Missed Work for H1N1 School Closings: Survey
4. ICU Patients at Risk for Rare Heart Rhythm Problem
5. Cook With Love This Valentines Day With Heart-Smart Recipes
6. Study finds racial gaps continue in heart disease awareness
7. Highmark Foundation Awards $120,000 to the American Heart Association
8. Womens Heart Disease Awareness Still Lacking
9. American Heart Association Rapid Access Journal Report: Study Finds Racial Gaps Continue in Heart Disease Awareness, Low Knowledge of Heart Attack Warning Signs Among Women
10. Migraine Linked to Increased Heart Attack Risk
11. PERSONALABS Offers Discounted Healthy Heart Online Blood Tests in February
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... June 20, 2017 , ... Caduceus International Publishing (CIP), ... announce a new online course entitled Personal & Community Health for ... strategies for achieving optimal well-being and teaches students how to apply them in ...
(Date:6/20/2017)... ... 2017 , ... HOUSTON – Brazos Towers at Bayou Manor is proud ... options for today’s modern senior. Brazos Towers at Bayou Manor has more than 50 ... offering them the services to support that lifestyle both now and in the future. ...
(Date:6/20/2017)... ... ... As a leading dental practice, Wall Centre Dental supports Stroke Awareness Month ... bleeding gums in Vancouver, BC, may be developing gingivitis, the first stage of ... and diabetes. Drs. Parviz Roshan, Siamak Tehrani and Milton Reskovich offer laser gum therapy ...
(Date:6/20/2017)... ... June 20, 2017 , ... In his newly appointed role ... May, Ph.D., recently accepted the distinguished Sun Corridor Export Award for his company’s ... (WNB), and 16 other businesses from Pima, Pinal, and Maricopa counties in Arizona, ...
(Date:6/20/2017)... ... ... Uniworld Boutique River Cruise Collection recently gave cruisers a chance to ... Joie de Vivre . What really sets this ship apart from the competition, however, ... enough to dock directly in Paris. With The Cruise Web’s new infographic, you can ...
Breaking Medicine News(10 mins):
(Date:6/5/2017)... The Cincinnati location of ... (NYSE: DPLO), has been awarded a Top Workplaces 2017 ... Results are based on an employee survey administered by WorkplaceDynamics, ... improvement. The survey measures several aspects of workplace culture, including ... ...
(Date:6/1/2017)... BLUE BELL, Pa. , June 1, 2017 /PRNewswire/ ... Nutriceuticals (PRN) and Veterinarian Recommended Solutions (VRS), and KD ... direct investment in Nutriceutical Holdings by KD Pharma Group. ... Nutriceutical Holdings with the option to acquire the entire ... ideal partner in KD. They are committed to growing ...
(Date:5/29/2017)... AVIV, Israel, May 29, 2017  Cellect Biotechnology Ltd. ... innovative technology which enables the functional selection of stem ... results for the first quarter ended March 31 st ... with our accomplishments in the first quarter of 2017," ... first quarter, we announced the treatment of the first ...
Breaking Medicine Technology: